UK markets open in 4 hours 16 minutes

Tecan Group Ltd. (TCHBF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
585.000.00 (0.00%)
At close: 1:49PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close585.00
Bid0.00 x 0
Ask0.00 x 0
Day's range585.00 - 585.00
52-week range245.00 - 585.00
Avg. volume3
Market cap7.485B
Beta (5Y monthly)0.12
PE ratio (TTM)61.54
EPS (TTM)9.51
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Tecan successfully completes the acquisition of Paramit

    Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Männedorf, Switzerland, August 2 2021 – The Tecan Group (SIX Swiss Exchange: TECN) announced today that it has successfully completed the acquisition of US-based Paramit Corporation and its affiliates (“Paramit”) for a total purchase consideration of USD 1.0 billion (CHF 920 million). On June 23, 2021, Tecan entered into a definitive agreement to acquire Paramit. Paramit, headquartered in Morgan Hill (CA), US

  • Globe Newswire

    Tecan expands its commercial reach, its capabilities and its US and Asia presence with the acquisition of Paramit Corporation

    Tecan to acquire Paramit Corporation, a leading OEM developer and manufacturer of medical devices and life sciences instruments, for a total consideration of USD 1.0 billion (CHF 920 million) In full year 2021, Paramit is expected to generate around USD 280m in sales (CHF 257m) and around USD 50m EBITDA (CHF 46m), before acquisition-related costs Transaction expected to be immediately and significantly accretive to earnings per share (EPS) upon closing Adds complementary expertise, broadens desi

  • Globe Newswire

    Tecan to present at UBS Global Healthcare Virtual Conference

    Männedorf, Switzerland, May 21, 2021 – The Tecan Group (SIX Swiss Exchange: TECN) today announced that it will present at the UBS Global Healthcare Virtual Conference next week. UBS Global Healthcare Virtual ConferenceDate: 25 May 2021Presentation and Fireside Chat: 4:00 pm CET (10:00 am EST) with Dr. Achim von Leoprechting, CEO, Tecan Webcast live under the "Investor Relations" tab of Tecan's website A replay of the webcast will be available after the presentation and will remain available for 30 days. About TecanTecan ( is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automation solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2020, Tecan generated sales of CHF 731 million (USD 778 million; EUR 683 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191). For further information: Tecan GroupMartin BraendleSenior Vice President, Corporate Communications & IRTel. +41 (0) 44 922 84 30Fax +41 (0) 44 922 88 Attachment Press Release